39456478|t|Lactobacillus Eats Amyloid Plaque and Post-Biotically Attenuates Senescence Due to Repeat Expansion Disorder and Alzheimer's Disease.
39456478|a|Patients with Alzheimer's disease and related dementia (ADRD) are faced with a formidable challenge of focal amyloid deposits and cerebral amyloid angiopathy (CAA). The treatment of amyloid deposits in ADRD by targeting only oxidative stress, inflammation and hyperlipidemia has not yielded significant positive clinical outcomes. The chronic high-fat diet (HFD), or gut dysbiosis, is one of the major contributors of ADRD in part by disrupted transport, epigenetic DNMT1 and the folate 1-carbon metabolism (FOCM) cycle, i.e., rhythmic methylation/de-methylation on DNA, an active part of epigenetic memory during genes turning off and on by the gene writer (DNMT1) and eraser (TET2/FTO) and the transsulfuration pathway by mitochondrial 3-mercaptopyruvate sulfur transferase (3MST)-producing H2S. The repeat CAG expansion and m6A disorder causes senescence and AD. We aim to target the paradigm-shift pathway of the gut-brain microbiome axis that selectively inhibits amyloid deposits and increases mitochondrial transsulfuration and H2S. We have observed an increase in DNMT1 and decreased FTO levels in the cortex of the brain of AD mice. Interestingly, we also observed that probiotic lactobacillus-producing post-biotic folate and lactone/ketone effectively prevented FOCM-associated gut dysbiosis and amyloid deposits. The s-adenosine-methionine (SAM) transporter (SLC25A) was increased by hyperhomocysteinemia (HHcy). Thus, we hypothesize that chronic gut dysbiosis induces SLC25A, the gene writer, and HHcy, and decreases the gene eraser, leading to a decrease in SLC7A and mitochondrial transsulfuration H2S production and bioenergetics. Lactobacillus engulfs lipids/cholesterol and a tri-directional post-biotic, folic acid (an antioxidant and inhibitor of beta amyloid deposits; reduces Hcy levels), and the lactate ketone body (fuel for mitochondria) producer increases SLC7A and H2S (an antioxidant, potent vasodilator and neurotransmitter gas) production and inhibits amyloid deposits. Therefore, it is important to discuss whether lactobacillus downregulates SLC25A and DNMT1 and upregulates TET2/FTO, inhibiting beta-amyloid deposits by lowering homocysteine. It is also important to discuss whether lactobacillus upregulates SLC7A and inhibits beta-amyloid deposits by increasing the mitochondrial transsulfuration of H2S production.
39456478	90	108	Expansion Disorder	Disease	OMIM:616452
39456478	113	132	Alzheimer's Disease	Disease	MESH:D000544
39456478	134	142	Patients	Species	9606
39456478	148	188	Alzheimer's disease and related dementia	Disease	MESH:D000544
39456478	190	194	ADRD	Disease	MESH:D000544
39456478	243	259	amyloid deposits	Disease	MESH:D058225
39456478	264	291	cerebral amyloid angiopathy	Disease	MESH:D016657
39456478	293	296	CAA	Disease	MESH:D016657
39456478	316	332	amyloid deposits	Disease	MESH:D058225
39456478	336	340	ADRD	Disease	MESH:D000544
39456478	377	389	inflammation	Disease	MESH:D007249
39456478	394	408	hyperlipidemia	Disease	MESH:D006949
39456478	501	514	gut dysbiosis	Disease	MESH:D064806
39456478	552	556	ADRD	Disease	MESH:D000544
39456478	600	605	DNMT1	Gene	1786
39456478	614	620	folate	Chemical	MESH:D005492
39456478	623	629	carbon	Chemical	MESH:D002244
39456478	793	798	DNMT1	Gene	1786
39456478	812	816	TET2	Gene	54790
39456478	817	820	FTO	Gene	79068
39456478	872	909	3-mercaptopyruvate sulfur transferase	Gene	4357
39456478	911	915	3MST	Gene	4357
39456478	927	931	H2S.	Chemical	MESH:D006862
39456478	961	973	m6A disorder	Disease	MESH:C535673
39456478	996	998	AD	Disease	MESH:D000544
39456478	1103	1119	amyloid deposits	Disease	MESH:D058225
39456478	1169	1173	H2S.	Chemical	MESH:D006862
39456478	1206	1211	DNMT1	Gene	1786
39456478	1226	1229	FTO	Gene	79068
39456478	1267	1269	AD	Disease	MESH:D000544
39456478	1270	1274	mice	Species	10090
39456478	1323	1336	lactobacillus	Species	1578
39456478	1359	1365	folate	Chemical	MESH:D005492
39456478	1370	1377	lactone	Chemical	MESH:D007783
39456478	1378	1384	ketone	Chemical	MESH:D007659
39456478	1423	1436	gut dysbiosis	Disease	MESH:D064806
39456478	1441	1457	amyloid deposits	Disease	MESH:D058225
39456478	1530	1550	hyperhomocysteinemia	Disease	MESH:D020138
39456478	1552	1556	HHcy	Disease	MESH:D020138
39456478	1593	1606	gut dysbiosis	Disease	MESH:D064806
39456478	1644	1648	HHcy	Disease	MESH:D020138
39456478	1747	1750	H2S	Chemical	MESH:D006862
39456478	1781	1794	Lactobacillus	Species	1578
39456478	1803	1809	lipids	Chemical	MESH:D008055
39456478	1810	1821	cholesterol	Chemical	MESH:D002784
39456478	1857	1867	folic acid	Chemical	MESH:D005492
39456478	1906	1922	amyloid deposits	Disease	MESH:D058225
39456478	1932	1935	Hcy	Chemical	MESH:D006710
39456478	1953	1972	lactate ketone body	Chemical	-
39456478	2026	2029	H2S	Chemical	MESH:D006862
39456478	2116	2132	amyloid deposits	Disease	MESH:D058225
39456478	2180	2193	lactobacillus	Species	1578
39456478	2219	2224	DNMT1	Gene	1786
39456478	2241	2245	TET2	Gene	54790
39456478	2246	2249	FTO	Gene	79068
39456478	2262	2283	beta-amyloid deposits	Disease	MESH:D058225
39456478	2296	2308	homocysteine	Chemical	MESH:D006710
39456478	2350	2363	lactobacillus	Species	1578
39456478	2395	2416	beta-amyloid deposits	Disease	MESH:D058225
39456478	2469	2472	H2S	Chemical	MESH:D006862
39456478	Negative_Correlation	MESH:D007783	MESH:D064806
39456478	Association	MESH:D006862	MESH:D064806
39456478	Negative_Correlation	MESH:D000544	79068
39456478	Negative_Correlation	MESH:D005492	MESH:D058225
39456478	Negative_Correlation	MESH:D007659	MESH:D058225
39456478	Negative_Correlation	MESH:D006862	79068
39456478	Negative_Correlation	MESH:D007659	MESH:D064806
39456478	Negative_Correlation	MESH:D007783	MESH:D058225
39456478	Negative_Correlation	MESH:D005492	MESH:D064806
39456478	Negative_Correlation	MESH:D005492	MESH:D006710
39456478	Association	MESH:D006862	4357
39456478	Association	MESH:D000544	1786
39456478	Association	MESH:D064806	1786

